InventisBio Statistics
Total Valuation
InventisBio has a market cap or net worth of CNY 6.79 billion. The enterprise value is 5.57 billion.
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InventisBio has 579.61 million shares outstanding. The number of shares has decreased by -1.06% in one year.
| Current Share Class | 579.61M |
| Shares Outstanding | 579.61M |
| Shares Change (YoY) | -1.06% |
| Shares Change (QoQ) | +1.88% |
| Owned by Insiders (%) | 10.01% |
| Owned by Institutions (%) | 36.94% |
| Float | 398.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 101.07 |
| PB Ratio | 5.46 |
| P/TBV Ratio | 5.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 83.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.92, with a Debt / Equity ratio of 0.01.
| Current Ratio | 13.92 |
| Quick Ratio | 13.47 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -301.67 |
Financial Efficiency
Return on equity (ROE) is -25.45% and return on invested capital (ROIC) is -16.92%.
| Return on Equity (ROE) | -25.45% |
| Return on Assets (ROA) | -16.00% |
| Return on Invested Capital (ROIC) | -16.92% |
| Return on Capital Employed (ROCE) | -30.74% |
| Weighted Average Cost of Capital (WACC) | 6.79% |
| Revenue Per Employee | 390,422 |
| Profits Per Employee | -2.08M |
| Employee Count | 191 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, InventisBio has paid 43,367 in taxes.
| Income Tax | 43,367 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.75% in the last 52 weeks. The beta is 0.46, so InventisBio's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -55.75% |
| 50-Day Moving Average | 16.31 |
| 200-Day Moving Average | 19.92 |
| Relative Strength Index (RSI) | 30.49 |
| Average Volume (20 Days) | 19,649,425 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, InventisBio had revenue of CNY 71.06 million and -379.24 million in losses. Loss per share was -0.66.
| Revenue | 71.06M |
| Gross Profit | 66.15M |
| Operating Income | -408.58M |
| Pretax Income | -379.20M |
| Net Income | -379.24M |
| EBITDA | -404.34M |
| EBIT | -408.58M |
| Loss Per Share | -0.66 |
Full Income Statement Balance Sheet
The company has 1.23 billion in cash and 17.49 million in debt, with a net cash position of 1.22 billion or 2.10 per share.
| Cash & Cash Equivalents | 1.23B |
| Total Debt | 17.49M |
| Net Cash | 1.22B |
| Net Cash Per Share | 2.10 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 2.27 |
| Working Capital | 1.27B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -272.87 million and capital expenditures -7.50 million, giving a free cash flow of -280.38 million.
| Operating Cash Flow | -272.87M |
| Capital Expenditures | -7.50M |
| Depreciation & Amortization | 4.24M |
| Net Borrowing | n/a |
| Free Cash Flow | -280.38M |
| FCF Per Share | -0.48 |
Full Cash Flow Statement Margins
| Gross Margin | 93.10% |
| Operating Margin | -575.00% |
| Pretax Margin | -533.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InventisBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.06% |
| Shareholder Yield | 1.06% |
| Earnings Yield | -5.66% |
| FCF Yield | -3.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
InventisBio has an Altman Z-Score of 68.23 and a Piotroski F-Score of 1.
| Altman Z-Score | 68.23 |
| Piotroski F-Score | 1 |